Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Non-Current Assets (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed Non-Current Assets for 5 consecutive years, with $57.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 10.6% to $57.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $223.1 million, a 6.47% increase, with the full-year FY2025 number at $57.7 million, up 10.6% from a year prior.
  • Non-Current Assets was $57.7 million for Q4 2025 at PROCEPT BioRobotics, up from $56.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $57.7 million in Q4 2025 to a low of $10.9 million in Q4 2021.
  • A 5-year average of $44.7 million and a median of $52.3 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: surged 238.25% in 2022, then decreased 3.65% in 2024.
  • PROCEPT BioRobotics' Non-Current Assets stood at $10.9 million in 2021, then soared by 238.25% to $36.7 million in 2022, then soared by 47.54% to $54.2 million in 2023, then decreased by 3.65% to $52.2 million in 2024, then increased by 10.6% to $57.7 million in 2025.
  • Per Business Quant, the three most recent readings for PRCT's Non-Current Assets are $57.7 million (Q4 2025), $56.8 million (Q3 2025), and $55.0 million (Q2 2025).